LEADER 04163nam 2200649 450 001 9910453288903321 005 20200520144314.0 010 $a0-19-936838-4 010 $a0-19-991807-4 035 $a(CKB)2550000001254540 035 $a(EBL)1665543 035 $a(SSID)ssj0001179889 035 $a(PQKBManifestationID)12478284 035 $a(PQKBTitleCode)TC0001179889 035 $a(PQKBWorkID)11185064 035 $a(PQKB)10531823 035 $a(StDuBDS)EDZ0001446590 035 $a(MiAaPQ)EBC1665543 035 $a(Au-PeEL)EBL1665543 035 $a(CaPaEBR)ebr10854983 035 $a(CaONFJC)MIL587827 035 $a(OCoLC)875894780 035 $a(EXLCZ)992550000001254540 100 $a20140413h20142014 uy 0 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt 182 $cc 183 $acr 200 00$aAsthma $ecomorbidities, coexisting conditions, and differential diagnosis /$fedited by Richard F. Lockey, Dennis K. Ledford ; with the World Allergy Organization 210 1$aNew York :$cOxford University Press,$d2014. 210 4$dİ2014 215 $a1 online resource (513 p.) 300 $aDescription based upon print version of record. 311 $a0-19-991806-6 311 $a1-306-56576-6 320 $aIncludes bibliographical references at the end of each chapters and index. 327 $aCover; Asthma; Copy Right; Dedication; Contents; Foreword; Preface; Contributors; Section one Immunologic; 1. Hypersensitivity pneumonitis; 2. Antineutrophil cytoplasmic antibody-positive vasculitis; 3. Allergic bronchopulmonary aspergillosis; 4. Immunodeficiency: innate,primary, and secondary; Section two Pulmonary; 5. Sleep apnea in children and the upper airway; 6. Asthma and obstructive sleep apnea; 7. Chronic obstructive pulmonary disease and irreversible airflow obstruction; 8. Bronchiectasis; 9. Bronchiolitis; 10. Genetic disorders and asthma; 11. Other pulmonary abnormalities 327 $a12. Pneumonia13. Cough; 14. Occupational asthma; Section three Cardiac and cardiovascular; 15. Adult cardiac conditions; 16. Pediatric cardiac conditions; 17. Pulmonary hypertension; Section four upper/extrathoracic airway; 18. Allergic rhinitis; 19. Nonallergic rhinopathies and lower airway syndromes; 20. Infectious comorbidities of asthma in the upper airway; 21. Nasal polyps and chronic rhinosinusitis; 22. Vocal cord dysfunction and paradoxical vocal fold motion disorder; Section five Gastrointestinal; 23. Gastroesophageal reflux; Section six Metabolic; 24. Obesity and asthma 327 $a25. Endocrine disorders26. Osteopenia and osteoporosis; 27. Pregnancy; Section seven Psychological issues; 28. Psychological factors; 29. Asthma, substance abuse, and tobacco use; Section eight Exercise; 30. Exercise-induced bronchoconstriction and asthma; Section nine Environmental and population effects; 31. Environmental protective and risk factors in asthma; Section ten Age; 32. Asthma over 65; Section eleven Food; 33. Atopic dermatitis, food allergy, and anaphylaxis; index 330 $aAsthma sufferers number approximately 200 million worldwide, with 15-20 million of those in the United States. Multiple comorbid conditions occur with asthma, including rhinitis, rhinosinusitis, gastroesophageal reflux disease, sleep apnea, vocal cord dysfunction syndrome, obesity, and chronic obstructive pulmonary disease (COPD). Without identifying and caring for comorbid conditions, asthma cannot be treated appropriately. Comorbidity of allergic diseases emphasizes that we must understand more about why different organs in individuals express allergy and others do not. The increase in multi 606 $aAsthma 606 $aDiagnosis, Differential 608 $aElectronic books. 615 0$aAsthma. 615 0$aDiagnosis, Differential. 676 $a616.2/38 702 $aLockey$b Richard F. 702 $aLedford$b Dennis K.$f1950- 712 02$aWorld Allergy Organization, 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910453288903321 996 $aAsthma$92108257 997 $aUNINA